Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. The company was incorporated in 2000 and is headquartered in Jinju-Si, South Korea.
Metrics to compare | 092040 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship092040PeersSector | |
---|---|---|---|---|
P/E Ratio | −3.1x | −11.0x | −0.5x | |
PEG Ratio | 0.08 | −0.07 | 0.00 | |
Price/Book | 1.3x | 2.4x | 2.6x | |
Price / LTM Sales | 0.9x | 9.0x | 3.0x | |
Upside (Analyst Target) | - | 0.0% | 48.7% | |
Fair Value Upside | Unlock | 7.7% | 9.2% | Unlock |